NSG
GILD icon

Nalls Sherbakoff Group’s Gilead Sciences GILD Stock Holding History

Nalls Sherbakoff Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$4.86K Hold
60
– – ﹤0.01% 305
2023
Q3 		$4.5K Hold
60
– – ﹤0.01% 307
2023
Q2 		$4.62K Hold
60
– – ﹤0.01% 309
2023
Q1 		$4.89K Buy
+60
New +$4.97K ﹤0.01% 307

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nalls Sherbakoff Group's GILD Position: Q4 2023 in Review

Nalls Sherbakoff Group held its Gilead Sciences (GILD) position steady in Q4 2023 at 60 shares worth $4.86K. The position accounts for ﹤0.01% of the portfolio, ranked #305.

Nalls Sherbakoff Group first reported a position in GILD in Q1 2023 and has held it in 4 quarters since. The position peaked at $4.89K in Q1 2023. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

  • Nalls Sherbakoff Group held 60 shares of Gilead Sciences worth $4.86K as of Q4 2023.
  • Nalls Sherbakoff Group left its Gilead Sciences share count unchanged in Q4 2023.
  • Gilead Sciences made up ﹤0.01% of Nalls Sherbakoff Group's portfolio in Q4 2023, its #305 holding.
  • Nalls Sherbakoff Group first reported a position in Gilead Sciences in Q1 2023 and has held it in 4 quarters since.
  • Nalls Sherbakoff Group's Gilead Sciences position peaked at $4.89K in Q1 2023.
  • 1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on Nalls Sherbakoff Group's 13F filing for Q4 2023, filed 9 Apr 2024.